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Section I. Abstract 
Problem: Cesarean sections (C/S) are among the most common operations in the United States 
and result in moderate visceral and somatic pain. Historically, C/S pain has been treated with 
opioid pain relievers. The U.S. Department of Health and Human Services declared the misuse of 
opioids an epidemic in 2017, leading healthcare providers and organizations to look inward at how 
opioids are prescribed and used at all levels of patient care.  
Context: A microsystem assessment on a 60-bed mother/baby unit indicated one of the highest 
average opioid administration rates per day for postoperative C/S patients in the organization’s 
region for the obstetrical service line.  
Interventions: A quality improvement project was implemented to address this problem. Based 
on an extensive literature review, a quality improvement team established a proposal for three 
interventions to decrease the average opioid use per day in this patient population. All interventions 
were non-pharmacological. The first was an abdominal binder that all C/S patients received upon 
arrival at the mother/baby unit. The second was an increased use of simethicone for postoperative 
gas pain. The third intervention was a pain management menu to guide nurses in providing 
postoperative pain management education. Due to the time constraints of the project, the quality 
improvement team did not implement the interventions of increasing simethicone use and the use 
of the pain management menu.  
Measures: The outcome measure was the average morphine equivalents per day administered 
postoperatively. The process measures included the rate of patients who received abdominal 
binders postoperatively, the rate of patients who received simethicone during their postpartum 
stays, and the rate of patients who received pain management menus. The balancing measure was 
the daily average delta pain score.  
  3 
Results: Data from June 2021 showed a 0.6 morphine equivalent decrease in the average daily 
morphine equivalent administration rate. Abdominal binder applications increased from 57% to 
86%, and the percentage of patients who did not receive a binder decreased from 43% to 14%. 
Average delta pain scores dropped 0.2 points, indicating patients did not verbalize additional pain 
following interventions.  
Conclusion: Maternity healthcare providers are responsible for adequately treating and managing 
postoperative pain to optimize recovery and encourage bonding of the new family unit. The use of 
non-pharmacological interventions can decrease pain without the undesirable side effects seen 
with opioid administration. Initial results showed a decrease in the administration of opioids 
postoperatively by increasing abdominal binder use among C/S patients. Further data will need to 
be collected to determine the long-term benefits of the interventions implemented.  
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Section II. Introduction 
The opioid use epidemic has reached all corners of the United States and has negatively 
impacted many American families. The opioid epidemic led the U.S. Department of Health and 
Human Services (HHS) in 2017 to declare current opioid use a public health emergency (HHS, 
2019). According to the Centers for Disease Control and Prevention (CDC, 2020), over 450,000 
people died from an opioid overdose from 1999 to 2018. Despite a recent 4% decrease, the 
number of overdose deaths was four times higher in 2018 than in 1999 (CDC, 2020).  
Healthcare organizations have responded to this “call to action” by looking 
introspectively at how opioids are used and prescribed at various levels in their macrosystems. A 
particular area of concern has been the use of opioids on surgical patients to manage 
postoperative pain. One of the most common inpatient surgical procedures performed in the U.S. 
is a cesarean section (C/S) (Agency for Healthcare Research and Quality [AHRQ], 2020). C/Ss 
result in moderate visceral and somatic postoperative pain, leading to prescription pain 
medication as a primary pain relief method (Burgess et al., 2019). According to Bateman et al. 
(2016), “approximately 1 in 300 opioid naïve women become addicted after cesarean birth,” a 
staggering statistic to perinatal care providers.  
Problem Description 
Morphine milligram equivalent (MME) is the standard unit of measurement when 
discussing risks associated with opioid use. MME is “the value assigned to opioids to represent 
their relative potencies” and “is determined by using an equivalency factor to calculate a dose of 
morphine that is equivalent to the ordered opioid” (RxPerts Industry Insights, n.d., p. 3). 
Healthcare organizations can pull data to determine the average MME per day to gauge 
  8 
adherence to recommended opioid prescribing guidelines and develop quality improvement plans 
to meet organizational goals.  
The Roseville medical center used in this quality improvement project utilized an 
evidence-based pathway, Enhanced Recovery After Surgery (ERAS), to reduce total MME 
throughout an obstetrical (OB) inpatient admission. The Mother/Baby (M/B) unit at this medical 
center saw a reduction from 15-20 ME/day to 5-10 ME/day with the introduction of ERAS to the 
OB service line in 2016 (Kaiser Permanente, 2021). The ERAS pathways have had overall 
success in controlling postoperative pain while still decreasing MME. The Roseville M/B unit 
met outcome measures in all ERAS metrics, except the average floor ME per day. The M/B unit 
has been consistently trailing in this metric compared to other medical centers in the OB service 
line. Floor ME is defined by the healthcare organization as “the rate per day of morphine 
equivalents given from Post Anesthesia Care Unit (PACU) discharge through postoperative day 
three (POD3)” (Kaiser Permanente, n.d.). The Roseville M/B unit has been consistently above 
average, fluctuating in the top four for the highest floor ME/day out of all OB service lines in 
this northern California healthcare organization. Currently, there is no benchmark for floor 
ME/day rates set by region. The goal for this metric is determined by the average floor ME/day 
rate for the region for each service area. The goal was to be within one standard deviation of the 
regional average. The desired floor ME/day changes monthly, depending on the regional 
average.  
This Roseville medical center delivers over 6,000 babies annually, with approximately 
1,500 delivered via C/S (Kaiser Permanente, 2021). A reduction in the amounts of opioids given 
while maintaining pain control can help optimize a postpartum women’s ability to care for 
herself and her infant (American College of Obstetricians and Gynecologists [ACOG], 2018). 
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Studies have shown that excessive postpartum pain can lead to depression, lower breastfeeding 
rates, and decreased bonding between the infant and mother (Lamping et al., 2020). Finding 
alternatives to opioids to treat postoperative pain in postpartum women is of continued 
importance in the quest to deliver excellent patient care and provide the healthiest start for a 
newly developed family unit. This quality improvement project aimed to decrease the floor 
ME/day for post-C/S patients by optimizing the use of non-opioid-related pain relief measures, 
while maintaining pain control in this patient population.  
Available Knowledge 
To facilitate a literature search and examine current evidence on the topic, A PICOT 
question was created and noted as: In mother-baby postoperative patients (P), how does the 
addition of a non-opioid pain relief bundle (I) affect floor ME/day rates (O) when compared to 
the existing floor ME/day rates in (C) by August 1, 2021 (T)? Multiple electronic searches were 
conducted from February 2, 2021 to February 25, 2021, in the Scopus, Cochrane Database of 
Systematic Reviews, CINAHL, and Pub Med databases using the following search terms: ERAS, 
Enhanced Recovery After Surgery, Cesarean Section, Pain Management, Multimodal 
Anesthesia, Opioids, Abdominal Binders, AND Simethicone. Limitations were set to include 
English only, articles, review, and publication date no earlier than 2015. A total of 47 articles 
resulted from the literature search. Seven articles were selected for review. The articles were 
excluded if the research was non-obstetric and if the results were outcomes that had been 
previously implemented through the ERAS pathway.  
Literature Review 
A literature review was completed to determine the evidence available of non-opioid pain 
relief measures available to patients post-C/S. The Johns Hopkins Nursing Evidence-Based 
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Practice (JHEBP) appraisal tool was utilized to assess the selected literature (see appendix A). 
The review included three Level I articles, two Level III articles, and two Level V articles. All 
three Level I articles provided evidence to support the use of abdominal binders post-C/S to 
decrease postoperative pain. Two of the articles were rated as Level I A (Boonploeng et al., 
2021) and (Abd-ElGawad et al., 2021), and one as Level I B (Gustafson et al., 2018). All three 
Level I studies provided evidence to support the use of abdominal binders post-C/S to control 
postoperative pain. Two retrospective, nonexperimental studies identified the characteristics of 
postpartum women who had an increased likelihood of higher opioid use after birth, potentially 
leading to opioid dependence. The studies were rated Level III-A (Bateman et al., 2016) and 
Level III B (Schmidt et al., 2018). Both articles identified several characteristics that should be 
considered when developing a quality improvement project to decrease MME in the postpartum 
population. Identifying patients at greater risk is instrumental in providing an individualized care 
plan to meet patient pain outcomes.  
The final two studies were quality improvement studies on inpatient maternity units to 
decrease MME on postpartum women. These studies were included in this literature review 
because they provided evidence of best practices that can be applied to similar care settings. Both 
studies were rated Level V A. The first quality improvement article (Burgess et al., 2019) 
detailed implementing a “comfort bundle” that included multiple EBP non-opioid pain relief 
measures. Postintervention data showed a 61% reduction in total MME after bundle elements 
were implemented, and continued acceptable pain scores reported by patients (Burgess et al., 
2019). The study provided non-opioid based interventions based on EBP that can be duplicated 
in similar care settings and produce positive results. The second quality improvement article 
(Lamping et al., 2020) described a “PainPak” protocol for OB patients in the inpatient setting. 
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Postintervention data showed significant decreases in MME administered post-cesarean and 
post-vaginal deliveries (Lamping et al., 2020). Postintervention data showed reductions in 
opioids prescribed at discharge. This study provided supported the use of multimodal anesthesia, 
specifically Tylenol and Ibuprofen, around the clock to effectively manage vaginal and C/S pain 
and to minimize administration of opioids resulting in decreased MME/day. The ERAS protocol 
previously implemented in the M/B unit stressed the importance of multimodal anesthesia 
(MMA) around the clock to manage pain effectively. Although the organization’s set goals 
surrounding the use of MMA were being met, this study further proved that this practice could 
be educational to both staff and patients.  
The evidence found in the studies can be combined into a pain relief bundle for post-C/S 
pain relief on the M/B unit. The pain relief bundle will be added to previously implemented 
ERAS protocols. Evidence obtained can reinforce the importance of ERAS elements in pain 
management and substantiate the expansion of non-opioid pain relief nursing interventions not 
previously covered in ERAS pathways (see Appendix A for the evaluation table of evidence).  
Rationale 
The Stevens Star Model of Knowledge Transformation was selected as the evidence-
based practice (EBP) framework to guide the transformation of the knowledge found in the 
literature review into a pain relief bundle on the M/B unit for post-C/S patients (Stevens, 2013). 
The Stevens Star Model guides the transformation of research into evidence-based nursing 
practice through a detailed five-step process (see Appendix B). The model is represented by a 
five-point star, where each point details the process of converting one form of knowledge to the 
next point on the star and ending with evidence-based practice. The first point is “Discovery” 
(initial research is obtained), the second point is “Evidence Summary” (synthesis of all evidence 
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is compiled into one statement), the third point is “Translation into Action” (clinical practice 
guidelines are developed), the fourth point is “Integration” (clinical guideline is implemented 
into practice), and the fifth point is “Evaluation” (the impact of the evidence-based practice 
change on patient outcomes is determined) (Stevens Star Model, 2013). The Stevens Star Model 
guided the implementation of evidence regarding the bundle elements into nursing practice on 
the M/B unit.  
Specific Aims 
The specific aim of this project was to decrease the average floor ME/day to be within 
one standard deviation of the regional average by August 2021.  
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Section III. Methods 
Context 
The M/B microsystem is a thriving 60-bed unit located within the Maternal Child Health 
(MCH) mesosystem of a 340-bed northern California medical center. The MCH mesosystem 
delivers more than 6,000 babies annually. The M/B department relies on the collaboration and 
teamwork of healthcare providers within the micro, meso, and macrosystems to successfully 
meet the needs of its patient population. The M/B microsystem was assessed using the Institute 
for Excellence in Health and Social System’s (IEHSS, 2021) supporting microsystem workbook 
(see Appendix C). A Strengths-Weaknesses-Opportunities-Threats (SWOT) analysis (see 
Appendix D) and a cost-benefit analysis (see Appendix E) were completed to aid in the creation 
of interventions and implementation plan.  
Microsystem Assessment 
The M/B department’s purpose is to work closely with the Labor and Delivery (L&D) 
department to provide care to patients and their newborns during the period from delivery till 
discharge home. In addition to postpartum care, the M/B unit cares for antepartum patients who 
are not immediately at risk for delivery, but require inpatient monitoring.  
The M/B’s patient population is entirely female and falls within the childbearing ages of 
14-50. In addition to adult patients, M/B cares for newborns from birth to 4-5 days of life on 
average. A majority of the M/B patients are transferred from L&D after either vaginal or 
cesarean delivery. In rare cases, patients need more care and get transferred to the intensive care 
unit.  
The M/B department operates with a variety of professionals, including 60 clinicians 
(physicians, midwives, and residents); 180 registered nurses; 8 unit assistants; 5 birth certificate 
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clerks; 13 nurse leaders; hearing screeners; and personnel from environmental services, dietary, 
and social services. The contribution from all M/B microsystem professionals creates a cohesive 
team environment and increases involvement in improvement projects. The standard M/B nurse 
assignment ratio is three couplets to one RN. Patient acuity impacts the configuration of nurse 
assignments. C/S patients in the first 24 hours post-delivery require higher patient care due to 
decreased mobility and increased postoperative monitoring. Pain can increase acuity in this 
patient population, warranting the need to optimize pain control. Effective pain management 
requires a multidisciplinary approach.  
SWOT Analysis 
The SWOT analysis revealed several strengths and opportunities that aided the success of 
this quality improvement project. Awareness of the weaknesses and threats helped determine 
potential barriers to successful implementation. Strengths and opportunities identified for the unit 
included high patient satisfaction scores, innovative staff, verbalizing a willingness to change, 
active participation in unit-based committees, collaboration opportunities with similar 
microsystems, and utilizing resources outside the microsystem. Weaknesses and threats included 
the amount of staff needing training on new changes, frequent short staffing, multiple 
simultaneously-occurring changes overwhelming the team, resistance by some to change 
established practices surrounding pain management, hospital-wide bed shortage, frequent delays 
in transferring patients to the M/B floor due to bed shortage, and delays or backorders on 
supplies.  
Cost-Benefit Analysis 
The costs for this quality improvement project included RN wages for the time spent in 
quality improvement meetings and the cost of increasing par levels for supplies needed for 
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interventions, such as abdominal binders, simethicone, and printing costs for pain management 
menus. The expected benefits of implementing this intervention were the savings in pain 
medication and possibly decreased patient length of stay.  
Intervention 
This improvement project aimed to decrease the average floor ME/day post-C/S while 
maintaining effective pain control for this patient population. Chart audits were completed before 
meetings with the quality improvement (QI) team to determine possible risk factors for high 
floor ME. There was a total of 1,740 C/S deliveries from May 2020 through April 2021. Chart 
audits of all patients revealed an average floor ME/day greater than 20. Seventy-two charts were 
audited for the following information: delivery date and time, average floor ME for the entire 
stay, anesthesia type, previous drug history, history of chronic pain diagnosis, BMI, history of 
weight loss surgery, and non-steroidal anti-inflammatory drug (NSAIDS) allergies. According to 
the literature review, all elements audited were plausible risk factors for increased use of pain 
medication postoperatively. Eight of the patients (11%) had no identified risk factors for 
increased ME per day, while the remaining 64 patients (89%) had between one and three of the 
identified risk factors (see Table 1). Data obtained from the chart audit were presented to the 
chief of obstetrical services, the chief of anesthesia, the M/B clinical nurse specialist, and the 
M/B quality nurse consultant in an interdisciplinary meeting to discuss the use of transversus 
abdominus planus (TAP) blocks and liposomal bupivacaine in C/S patients. TAP blocks with 
liposomal bupivacaine are regional nerve blocks administered by an anesthesiologist that can 
relieve pain in the region for a duration of up to 120 hours (Nedeljkovic et al., 2020). The use of 
TAP blocks and liposomal bupivacaine were new additions to multimodal analgesia pain control 
options for C/S anesthesia at this medical center. Based on the data, the anesthesia provider 
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added allergies or contraindications to NSAIDs to the recommended list of patient conditions 
that would benefit from TAP blocks and liposomal bupivacaine. Previously identified conditions 
for TAP blocks included patients with general anesthesia and a history of a chronic pain disorder. 
Although TAP blocks were not a planned intervention for this quality improvement project, the 
goal of implementing the TAP blocks mirrored the specific aim of this quality improvement 
project and, therefore, impacted the results.  
Figure 1 
Risk Factors for ME >20 
 
 
The proposed intervention for this project was a postoperative pain relief bundle that 
would be initiated upon admission to the M/B floor. The postoperative pain relief bundle was 
implemented in multiple phases to ensure each bundle component was effectively and 
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Education for both M/B staff and patients was essential to the success of these 
interventions. M/B staff were resistant to changes in how postoperative pain was treated. 
Obtaining buy-in from the nursing staff was critical to successful implementation. Educating 
patients on available pain management measures post-C/S was another essential element to the 
improvement project. Standardizing the education given by M/B RNs to patients was a necessary 
step to achieve the desired outcomes.  
The QI team consisted of key stakeholders, including three M/B RNs, the M/B nurse 
manager, an L&D ANM, a certified nurse-midwife, the chief of obstetrical services, the M/B 
clinical nurse specialist, and the M/B quality nurse consultant. During the first meeting, the QI 
team decided to implement first the abdominal binders to all post-C/S patients upon admission to 
the M/B unit. The QI team discussed possible barriers in this project. The first PDSA cycle 
began on Monday, June 21, 2021. Huddle messages were given to M/B and L&D staff 
explaining the planned interventions in preparation for the first PDSA cycle. The M/B weekly 
newsletter titled, “Friday Focus Notes,” summarized the intervention, including instructions on 
when and how to place the abdominal binder and the evidence supporting the intervention. The 
newsletter contained a screenshot of how to document the placement of an abdominal binder, a 
photo of the recommended binder, and instructions on the setup of a postpartum room with the 
binder. One barrier identified was the supply of abdominal binders on the unit. To address this, 
communication was initiated with the supply chain manager to ensure the necessary quantity.  
The next element of the bundle was the regular use of simethicone. Complaints of gas 
pain and bloating are common after abdominal surgeries, such as C/Ss (Burgess et al., 2019). 
Simethicone is a chewable antiflatulent with minimal side effects (Burgess et al., 2019). The QI 
team hypothesized that a barrier to its regular use was the lack of an order on postpartum order 
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sets. M/B staff reported not giving simethicone due to the time-consuming task of contacting the 
physician for an order. Due to the length of time needed to change all physician’s preselected 
order sets, the request for the order set change was initiated before implementing the next bundle 
element. The QI team contacted information technology support for the perinatal domain, with 
endorsement from the chief of obstetrics at this medical facility, with the request to update the 
post-cesarean order sets to include preselecting simethicone. The chief of obstetrics emailed 
communication to all obstetrical physicians at this medical center to change their preselected 
order sets to include simethicone. In addition to preselecting simethicone, the request was made 
to preselect the order for abdominal binders on the postpartum C/S order set.  
The final element of the bundle was a postoperative pain relief “menu,” which was used 
upon admission to M/B to guide pain management education between the M/B nurse and the 
patient. The QI team determine specific details of the pain relief menu.  
Study of Intervention 
The QI team utilized resources available through the Institute for Healthcare 
Improvement (IHI, 2021), including the Model for Improvement and the PDSA worksheet, to 
complete a series of interventions (see Appendix F). The first PDSA cycle included abdominal 
binders for all post-C/S patients upon arrival to the M/B unit. The team met bi-weekly to review 
the results, discuss barriers, and plan the next steps. Future PDSA cycles will include education 
on regular simethicone use postoperatively and education and use of the pain management menu 
upon admission and through the postpartum stay. Simethicone use will be measured by chart 
audits identifying the amount given during the hospital admission. Use of the pain management 
menu will be measured by audits completed through nurse leader rounds. The nurse leader will 
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ensure the menu was present at the bedside and if the patient reported receiving education on the 
different modes of pain relief.  
A team charter was used (see Appendix G), including a driver diagram (see Appendix H) 
and timeline (see Appendix I), to organize and plan interventions. Preintervention data were 
collected on all C/S charts starting June 1, 2021. Charts were audited for abdominal binder 
application, BMI greater than 40, and simethicone use. Abdominal binder usage was separated 
into the following categories: abdominal binder applied upon admission, within 12 hours of 
admission, 12 to 24 hours of admission, greater than 24 hours after admission, or no abdominal 
binder use throughout admission. All C/S patient charts will be audited daily. The number of 
simethicone doses per admission will be audited as well as if simethicone was ordered 
postoperatively. Daily floor ME rates will be reviewed weekly when regional ERAS metric data 
is updated. Regional ERAS data are approximately 1 week behind.  
Measures 
The primary outcome measure for this project was the average floor ME/day rate 
obtained through the weekly ERAS reports. The project had three process measures and one 
balancing measure to determine the success of the interventions. The process measures included 
the percentage of patients given abdominal binders postoperatively, the percentage of patients 
given simethicone during their inpatient postoperative recoveries, and the percentage of patients 
given postoperative pain management education upon arrival to the M/B unit. The process 
measure data were obtained through daily chart audits and weekly ERAS reports. This project 
aimed to increase abdominal binders placed on admission from 15% to 90%. The goal for 
simethicone was to raise its use from the previous administration rate of 43% to 80%. The goal 
for educating patients upon admission regarding pain management options during recovery was 
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100%. The balancing measure for the project was the average delta pain scores (DPSS). DPSs 
are reported on the weekly ERAS reports and indicate if interventions unintentionally increase 
the patient’s report of pain. The DPS is defined as the patient’s current pain score minus the 
patient’s acceptable level of pain (Kaiser Permanente, n.d.). The average DPS for the patient 
admission is reported weekly in the ERAS report. The goal for the project was to decrease the 
average floor ME/day, while maintaining or lowering the average DPSs.  
Ethical Considerations 
In 1999, legislation was passed to ensure the proper assessment and treatment of pain in 
the healthcare setting (Baker, 2017). This led to the concept of pain as the fifth vital sign and a 
subsequent drastic increase in the prescribing and use of opioids to treat pain. With the rise in 
opioid prescribing came the opioid epidemic in the U.S. and a call to action for the healthcare 
organization to decrease opioid use. When healthcare organizations design quality improvement 
projects intending to reduce opioid use, they must avoid increasing patient pain inadvertently. 
Proper assessment and management of postoperative pain are vital to the healing process. The 
importance of the messaging for education to both staff and patients should not relay a message 
that opioids are inappropriate for the treatment of pain. Pain is a subjective experience and 
patient experience scores related to adequate pain relief will be monitored during the 
implementation of this project.  
This project was reviewed by the University of San Francisco and was approved as an 
evidence-based change in practice project; therefore, IRB approval was not required. See 
Appendix J for the Statement of non-research determination form. 
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Section IV. Results 
Chart audits were completed for all C/S patients to track the outcome, process, and 
balancing measures. As previously stated, floor ME rates are reported weekly in an ERAS report 
and are one week behind. Charts were audited for abdominal binder use, type of anesthesia used, 
simethicone order, simethicone administration, and previously stated risk factors for increased 
narcotic use. A total of 147 charts were audited over a 4-week timeframe from June 21 through 
July 18, 2021. Floor ME and average DPS data were available through July 14, 2021. Pre-
intervention audits were completed on 33 charts between June 14 through June 20, 2021 for 
abdominal binder use and risk factors for increased narcotics use. The 4-week timeframe in 
which postintervention data were collected involved unplanned barriers to project 
implementation. A census surge in M/B resulted in patients held in L&D due to no available 
beds in M/B and a resulting staffing shortage.  
Process Measures 
The first intervention implemented was application of an abdominal binder upon arrival 
to the M/B unit. Postintervention data showed abdominal binder use during the whole 
postpartum stay increased from 57% to 86%, and no abdominal binder use decreased from 43% 
to 14% (see Figure 2). The second planned intervention was the increased use of simethicone 
during postpartum admission. The QI team hypothesized that simethicone was not used due to no 
order to administer. An email was sent to all providers by the chief of obstetrical services to 
preselect simethicone on the postpartum C/S order set on July 14, 2021. Chart audits showed 
orders for simethicone increased from 78% to 82%. Charts were audited for the administration of 
simethicone during the postpartum admission, considering the relatively high percentage of C/S 
charts with preexisting orders for simethicone. One hundred sixteen patients had orders to 
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receive simethicone, as needed, for gas pain and only 43% received at least one dose of 
simethicone during their admissions. Future efforts to increase simethicone use will focus on 
educating RNs and patients on the benefits of simethicone in decreasing pain in this patient 
population.  
Figure 2 
Abdominal Binder Application 
 
 
The last process measure and intervention was a pain management menu that helped 
guide education on postoperative pain management options. The pain management menu was 
created and piloted by the QI team before the full unit rollout.  
Outcome Measure 
The outcome measure for this project was to decrease the M/B floor ME within one 
standard deviation of the regional average. Closing data for June 2021 showed the M/B average 
floor ME 0.4 MEs above the regional average for June, and therefore within one standard 
  23 
deviation (see Appendix K). There was a 0.6 M/B floor ME decrease from May 2021 to June 
2021.  
Balancing Measure 
The balancing measure for this project was the average DPS. Balancing measure data 
were collected through the weekly ERAS reports. Average DPSs were maintained through the 
initial implementation of this project. There was a 0.2 decrease in average DPSs reported from 
May 2021 to June 2021, meaning patients reported their pain as more diminutive than their pain 
tolerance level (see Appendix L). As this project progressed, average DPSs continued to be 
followed to ensure the interventions did not inadvertently increase reported pain levels.  
  
  24 
Section V. Discussion 
Interventions implemented in June 2021 initially showed a decrease in floor ME on this 
M/B unit. The planned interventions of regular use of simethicone and the pain management 
menu will need to be implemented and measured. Future data will determine the long-term 
success of this project. The sustainability plan includes continued meetings with the QIC team, 
PDSA cycles, and regular communication with M/B staff on interventions implemented and 
supporting data. Maintaining sustained use of abdominal binders has proven challenging. Plans 
to maintain sustainability for this intervention include continuing to huddle messages to staff 
regarding the evidence-based practice of using an abdominal binder in this patient population to 
decrease pain, regular data updates with M/B staff, ensuring adequate stock of abdominal 
binders, and including abdominal binders in the room set-up on M/B.  
Key Findings 
Key findings for this project include the intervention of an abdominal binder that has 
successfully decreased the M/B floor ME rate. The rollout of TAP blocks coincided with the 
initiation of this project. Seven C/S patients received a TAP block from June 2021 to July 2021, 
four of which occurred when time charts were audited. The impact of TAP blocks versus the 
effects of abdominal binder application on the average floor ME rate for June 2021 could not be 
determined. Regardless of which methods decreased floor ME rates for June 2021, the goal of 
the project was met initially. The enduring impact of this project will be ongoing planned 
interventions.  
Lessons Learned 
One lesson learned was the importance of sustainability. Two weeks after implementing 
the project, a QI team meeting was postponed due to multiple members of the team having 
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planned vacations. An increase in the overall census and a subsequent decrease in huddling the 
intervention with the M/B staff occurred simultaneously. This was evident in the data analysis of 
the percentage of patients who received abdominal binders on admission during this period. The 
first week after implementation, 60% of the patients received abdominal binders on admission. 
Week two saw an increase to 62%, but by week four, abdominal binders on admission dropped 
to 32%.  
Conclusion 
The extent of the opioid epidemic has reached all sectors of society, including our 
maternal child health population. Healthcare providers must carefully monitor how and when 
narcotics are used to decrease the opportunities for addiction. C/Ss are one of the most common 
surgical procedures done in the United States. The subsequent pain results in inpatient and 
discharge prescriptions for opioids, leading to a staggering statistic of one in 300 women with no 
history of opioid abuse becoming addicted to opioids after C/S delivery (Burgess et al., 2019). 
The use of evidence-based non-pharmacological interventions to control pain will assist in 
decreasing postoperative opioid administration and optimize the ability of postpartum women to 
care for themselves and their infants.  
This project aimed to decrease inpatient postpartum opioid use on a M/B unit within a 
prominent northern California medical center. Before starting this project, this M/B unit had one 
of the highest rates of opioid administrations in this patient population compared to other 
regional medical centers in the same service line. After an extensive literature search, data 
analysis, and chart audits, a unit-based QI team was developed to address the problem. Based on 
the information collected, planned interventions to decrease narcotic use in this patient 
population included applying abdominal binders on all C/S patients, regular use of simethicone, 
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and a pain management menu to guide patients in pain management options. Beginning in June 
2021, abdominal binders were applied to all C/S patients. Resulting data showed a reduction in 
opioid use; therefore, the specific aim of this project was met.  
In June 2021, the average floor ME on M/B was within one standard deviation of the 
regional average. Additionally, the average floor ME decreased by 0.6 ME from May 2021 to 
June 2021. Due to allotted time constraints, increasing use of simethicone and the pain 
management menu interventions were not implemented. The plan for this project included 
ongoing monthly meetings with the QIC team to complete PDSA cycles on the remaining 
interventions. Projects such as this one can aid similar microsystems in achieving outcomes 
related to decreasing opioid use in this patient population. In turn, this will support the global 
aim to improve the health and wellbeing of our maternal child population in the United States.   
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Section VII. Appendices 
Appendix A. Evaluation Table 
PICOT Question: In mother-baby postoperative patients (P), how does the addition of a non-opioid pain relief bundle (I) affect floor 
ME/day rates (O) when compared to the existing floor ME/day rates in (C) by August 1, 2021 (T)? 
Study Design Sample Outcome/Feasibility 
Evidence 
Rating 
Gustafson, J. L., Dong, F., Duong, J., & 
Kuhlmann, Z. C. (2018). Elastic abdominal 
binders reduce cesarean pain 
postoperatively: A randomized control pilot 
trial. Kansas Journal of Medicine, 11(2), 
48–53. 
https://doi.org/10.17161/kjm.v11i2.8687 
RCT Sixty participants at the 
beginning of the trial, 56 
completed the trial.  
Utilizing abdominal binders decreased postsurgical pain 
reported by participants.  
 
Useful in providing evidence to support the use of abdominal 
binders on post-cesarean (C/S) section patients to decrease 
pain.  
I B 
Burgess, A., Harris, A., Wheeling, J., & 
Dermo, R. (2019). A quality improvement 
initiative to reduce opioid consumption 
after cesarean birth. The American 





MME data were collected pre- 
and postintervention and 
included total MME given to all 
patients during their inpatient 
stays. The baseline data 
collected on bundle component 
interventions implemented was 
collected from 209 cesarean 
births over a 3-month period. 
Postintervention data were 
collected from 130 cesarean 
births. 
Postintervention data showed a 61% reduction in total MME 
provided to patients during the inpatient stay. All bundle 
components showed improvement in consistency of use when 
compared to pre-intervention. A positive relationship can be 
drawn from implementing bundle components and a total 
decrease in MME.  
 
Provides CNLs with an example of an effective quality 
improvement project for decreasing MME in the postpartum 
patient population. It can be used as a best practice guidance 
for implementation in other postpartum units.  
V A 
Schmidt, P., Berger, M. B., Day, L., & 
Swenson, C. W. (2018). Home opioid use 
following cesarean delivery: How many 
opioid tablets should obstetricians 
prescribe? The Journal of Obstetrics and 





141 post-C/S women.  Increased opioid pain medication post-cesarean delivery was 
associated with infants >3560g, operative time >59.5 mins, 
and a more opioid tablets prescribed at discharge. The study 
supports decreased amounts of opioids prescribed at 
discharge depending on patient risk factors.  
 
Provides risk factors and characteristics of patients who may 
consume a higher-than-average amount of opioids. Provides 
evidence for decreasing the number of opioids given at 
discharge in the postpartum patient population.  
III B 
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Study Design Sample Outcome/Feasibility 
Evidence 
Rating 
Bateman, B. T., Franklin, J. M., Bykov, K., 
Avorn, J., Shrank, W. H., Brennan, T. A., 
Landon, J. E., Rathmell, J. P., Huybrechts, 
K. F., Fischer, M. A., & Choudhry, N. K. 
(2016). Persistent opioid use following 
cesarean delivery: Patterns and predictors 
among opioid-naive women. American 






80,127 opioids naïve, post-C/S 
women 
 Two hundred eighty-five opioid naïve women from the study’s 
total participants developed a persistent opioid dependency 
after their C/S. Characteristics were identified that increased 
the likelihood of opioid dependence developing. Data from the 
study can be used to identify who is at the most significant 
risk.  
 
Provides data for a CNL when presenting to stakeholders 
regarding the severity of opioid addiction in the maternity 
population. Identifies characteristics and patterns of patients in 
the maternity population that could become persistent opioid 
users that can be used when developing a QI project aimed at 
MME reduction in this patient population.  
III A 
Lamping, M., Gajus, J., & Gonzalez, A. 
(2020). A project to reduce opioid 
administration for women in the 
postpartum period. Nursing for Women’s 




The pilot phase included 210 
women post vaginal or cesarean 
birth; the complete 
implementation phase included 
5,560 women post vaginal or 
cesarean delivery.  
Postintervention data showed significant improvement in 
opioid use post-delivery. Increase of 41.8% seen in women 
not requiring any opioid medication in cesarean group and 
78% in vaginal group. MME decreased by 51% in cesarean 
group and 64% in vaginal delivery group. Opioids prescribed 
at discharge decreased 53% in cesarean group and 90% in 
vaginal delivery group.  
 
Provided evidence for use of multimodal anesthesia, 
specifically Tylenol and Ibuprofen, around the clock on 
postpartum patients to decrease MME administered.  
V A 
Boonploeng, K., Pratipanawatr, S., & 
Tangsiriwatthana, T. (2021). Abdominal 
binder for improving postoperative 
physical function after benign gynecologic 
surgery: A randomized controlled trial. 
Thai Journal of Obstetrics and 
Gynaecology, 29(1), 10–16. 
RCT 60 of the 70 participants 
consented to participate in the 
study after exclusion criteria 
were applied.  
Abdominal binder group showed more significant physical 
function in 6-minute walk test when compared to non-
abdominal binder group. Binder group reported decreased 
pain scores when compared to non-binder group.  
 
Provided supportive evidence on use of abdominal binders 
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Study Design Sample Outcome/Feasibility 
Evidence 
Rating 
Abd-ElGawad, M., Said Ali, A., 
Abdelmonem, M., Elshamy, N. H., 
Abdeltawab, A. K., Abd-el-Shafea, M., 
Rund, N. M., Fadlalmola, H. A., Ashour, A. 
S., & Almohamady, M. (2021). The 
effectiveness of the abdominal binder in 
relieving pain after cesarean delivery: A 
systematic review and meta-analysis of 
randomized controlled trials. International 





6 RCT studies were included 
with combined 703 patients.  
The conclusion stated abdominal binders are effective in the 
relief of pain and discomfort after cesarean delivery.  
 
Provides EBP support for the inclusion of abdominal binders 
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Appendix C. Microsystem Assessment 
 
© 2001, Trustees of Dartmouth College, Godfrey, Nelson, Batalden, Institute for Healthcare Improvement     
Adapted from the original version, Dartmouth-Hitchcock,  Version 2, February 2005 
6 
Inpatient Unit Profile 
A. Purpose: 
Why does your unit exist? The Kaiser Roseville Mother/Baby unit works in close collaboration with Kaiser Roseville’s Labor and Delivery unit to 
provide care to patients and their newborns during the period from delivery till the patient and newborn can be discharged home. In addition to 
postpartum care, Kaiser Roseville’s Mother Baby unit cares for antepartum patients that are not immediately at risk for delivery but require inpatient 
monitoring.  
 Site Contact: Angela Goyette Date: 9/29/20 
Administrative Director: Kim Menzel Nurse Director: Debbie Reitter Medical Director: Richard Floris 
B. Know Your Patients:  Take a close look into your unit, create a “high-level” picture of the PATIENT POPULATION that you serve.  Who are 
they?  What resources do they use?  How do the patients view the care they receive?        
Est. Age Distribution of Pts: %  List Your Top 10 Diagnoses/Conditions  Patient Satisfaction Scores % Always 
19-50 years 55   1. Vaginal Delivery 6. Vaginal Bleeding  Nurses 98 % 
51-65 years 








3. Preterm Labor 






















Discharge % Yes 
88% 
% Females 75     Overall % Excellent 78% 
Living Situation  %  Point of Entry %  
Pt Population Census: Do these numbers 
change by season? (Y/N) 
Y/N 
Married    Admissions   Pt Census by Hour Y 
Domestic Partner   Clinic   Pt Census by Day Y 
Live Alone    ED   Pt Census by Week Y 
Live with Others    Transfer   Pt Census by Year Y 
Skilled Nursing Facility   Discharge Disposition %  30 Day Readmit Rate 2% 
Nursing Home   Home   Our patients in Other Units <1% 
Homeless   Home with Visiting Nurse   Off Service Patients on Our Unit 25% 
Patient Type LOS avg. Range  Skilled Nursing Facility   Frequency of Inability to Admit Pt <1% 
Medical    Other Hospital   *Complete “Through the Eyes of 
Your Patient”, pg 8 
Surgical    Rehab Facility   
Mortality Rate   Transfer to ICU   
C. Know Your Professionals:  Use the following template to create a comprehensive picture of your unit.  Who does what and when?  Is 












Admitting Medical Service % 
MD Total     200 Internal Medicine 0 
Hospitalists Total     6 Hematology/Oncology 0 
Unit Leader Total     8 Pulmonary 0 
CNSs Total     1 Family Practice 0 
RNs Total     200 ICU 0 
LPNs Total     0 Other -OB 100 
LNAs Total     0 
Supporting Diagnostic Departments 
Residents Total     20 
Technicians Total     0 (e.g. Respiratory, Lab, Cardiology,  
Secretaries Total     1 Pulmonary, Radiology) 
Clinical Resource Coord.     0  
Social Worker     4 
Lab, Respiratory, Radiology, 
Cardiology, Pulmonary 
Health Service Assts.     0  
Ancillary Staff     15  
Do you use Per Diems?    __X___Yes         ______NO Staff Satisfaction Scores % 
Do you use Travelers?    ___X__Yes         ______NO How stressful is the unit?   % Not Satisfied 10% 
Do you use On-Call Staff?    ___X__Yes         ______NO Would you recommend it as a good place to work? % Strongly Agree 90% 
Do you use a Float Pool? ___X__Yes         ______NO    
*Each staff member should complete the Personal Skills Assessment and “The Activity Survey”, pgs 10 - 12  
D. Know Your Processes:  How do things get done in the microsystem?  Who does what?  What are the step-by-step processes?  How 
long does the care process take?  Where are the delays?  What are the “between” microsystems hand-offs?   





Beds___60__ a) Overall admission and treatment process Check all that apply 
b) Admit to Inpatient Unit x  Standing Orders/Critical Pathways 
# Turnovers/Bed/Year _7200_____ 
c) Usual Inpatient care  x  Rapid Response Team 








© 2001, Trustees of Dartmouth College, Godfrey, Nelson, Batalden, Institute for Healthcare Improvement     
Adapted from the original version, Dartmouth-Hitchcock,  Version 2, February 2005 
7 
Linking Microsystems 
e)  Discharge process x  Multidisciplinary/with Family Rounds (e.g.  ER, ICU, Skilled Nursing Facility )                   
f)  Transfer to another facility process ¨  Midnight Rounds   
g)  Medication Administration x  Preceptor/Charge Role 
Labor and Delivery 
Neonatal Intensive Care Unit (NICU) 
Intensive Care Unit 
Emergency Department 
h)   Adverse event x  Discharge Goals  
2.   Complete the Core and Supporting Process Assessment Tool, pg 14   
E. Know Your Patterns:  What patterns are present but not acknowledged in your microsystem?  What is the leadership and social pattern?  
How often does the microsystem meet to discuss patient care?  Are patients and families involved?  What are your results and outcomes?   
• Does every member of the unit meet 
regularly as a team?  Unit meetings are 
offered monthly, but not all employees 
attend • Do the members of the unit regularly 
review and discuss safety and reliability 
issues?  Yes 
• What have you successfully changed? 
HCHAP scores 
• What are you most proud of? Improving 
communication lines between staff and 
leadership.  
• How frequently? Monthly 
• What is your financial picture? Improving 
with the addition of tracking tools to 
adequately recode staff appropriately 
and staff the unit according to patient 
census and acquity.  
• What is the most significant pattern of variation? Workflows from 
shift to shift, communication, and the need to develop standard 
work.  
*Complete “Metrics that Matter”, pgs 20 & 21 
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•Large MB unit with 60 beds
•High patient satisfaction scores
•Large core RN staff 
•Competitive wages
•Innovative staff 
•Active participation in unit-based 
committees and voice `of nursing
•Staff express willingness to change 
processes to decrease narcotic use on 
unit
Weaknesses
•Long onboarding process for new 
hires
• Inconsistent staffing leading to OT 
booked
•Short staffing leading to overworked 
staff
•Frequent changes leading to 
overwhelmed staff
•Large number of staff to train on new 
processes 
•Resistance to change in establish 
practices
Opportunities
•Collaboration opportunities with 
similar microsystems within 
organization.
•Utilization of resources outside of 
unit available.
Threats
•Bed shortage in adult services 
resulting in MB beds used for non-
postpartum patients
•Delays in transferring patients to MB 
post cesarean section due to no 
available beds in MB
•Delays in obtaining needed supplies 
from central supply
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Appendix E. Cost-Benefit Analysis 
FTE Expense 
180 staff, 5-minute education during the beginning of shift huddle and staff meetings. Quality 
improvement team meetings included $86 per hour per RN. Other team members are exempt and 
work the meeting into their regularly scheduled shift. 
Non-FTE Expense 
Abdominal binders cost $4.43 x 150 per month 
The total cost for the first year with FTE and Non-FTE expenses is $11,328 
 
FTE Expense Startup Annual Cost Total Cost First Year 
Education during a staff meeting $0 $0 
$0 (already in the annual 
budget) 
Education during huddle $0 $0 
$0 (already in the annual 
budget) 
Committee meeting time: 
$86/hour per RN  
3 RNs x 3 startup 
meetings = $258 
3 RNs x 12 (monthly 
meetings) = $3,096 $3354 
 
Non-FTE Expense Startup Annual Cost Total Cost First Year 
Abdominal Binders 
$4.43 x 150 per 
month = $664.5 $7974 $7974 
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Appendix F. IHI PDSA Cycle Worksheet 
 
PDSA Worksheet (short version) 
1: Define your aim, the overall goal you wish to achieve. 2. Plan the first (or next) test of change toward achieving the 








Describe your first (or next) test of change: 
 
 
Who is responsible: 
 
 
When is it to be done: 
 
 










Predict what will happen when the test is performed: List measures for assessing the predictions: 
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Do  
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Appendix G. Project Charter  
Decreasing the average daily floor Morphine Equivalents (ME) project. 
 
Global Aim: The global aim of this project is to decrease the use of opioids and increase the 
utilization of non-opioid options for pain management in women post-cesarean section delivery.  
 
Specific Aim: This project aims to decrease the floor ME per day rate for post-cesarean section 
patients from 5.1 to 4.6 ME/day by August 2021.  
 
Background:  
This Roseville medical center delivers over 6000 babies a year, with approximately 1500 
delivered via cesarean section (Kaiser Permanente, 2021). One of the most common inpatient 
surgical procedures performed in the US is a cesarean section (Agency for Healthcare Research 
and Quality [AHRQ], 2020). Cesarean sections result in moderate visceral and somatic 
postoperative pain, leading to prescription pain medication as a primary pain relief method 
(Burgess et al., 2019). According to Bateman et al. (2016), “approximately 1 in 300 opioid naïve 
women become addicted after cesarean birth,” a staggering statistic to perinatal care providers. A 
reduction in the amounts of opioids given while maintaining pain control can lead to the 
optimization of a postpartum women’s ability to care for herself and her infant (American 
College of Obstetricians and Gynecologist [ACOG], 2018). Studies have shown excessive 
postpartum pain can lead to depression, lower breastfeeding rates, and decreased bonding 
between the infant and mother (Lamping et al., 2020). Finding alternatives to opioids to treat 
postoperative pain in postpartum women is of continued importance in the quest to deliver 
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excellent patient care and provide the healthiest start for a newly developed family unit. This 
quality improvement project aims to decrease the average daily floor M.E./day administered for 
post-cesarean section patients by optimizing the use of non-opioid related pain relief measures 
while maintaining pain control in the patient population.  
Sponsors 
Chief Nursing Executive D.R. 
MCH Director M.B 
Mother/Baby Manager A.G. 
Chief of Obstetrics J.C 
 
Goals 
This project’s overall purpose is to decrease the average daily floor ME administered post-
cesarean section after discharge from the PACU. This Roseville M/B unit is currently the fourth 
highest in the Northern California region for average daily floor ME. Although significant 
improvement has been made in post-op pain management after ERAS implementation in 2016, 
work is still needed to decrease opioid use postoperatively. Effective pain management can lead 
to increased infant bonding, increased breastfeeding rate, and a faster recovery for the patient, 
making pain management a pressing issue on the M/B unit (American College of Obstetricians 
and Gynecologist [ACOG], 2018). A comprehensive literature review of non-opioid pain relief 
measures was completed. In addition to ERAS protocols previously implemented, the following 
interventions were selected for this project to decrease the daily floor ME rates:  
1. Thorough education on postoperative pain management upon admission/transfer to 
the M/B unit.  
  42 
 
2. Providing an abdominal binder for use throughout the postpartum stay, including 
correct sizing and patient education on use.  
3. Administration of Simethicone for gas pain relief during postpartum admission.  
 
Measures 
Measure Data Source Target 
Outcome   
Average Floor ME/day rate ERAS weekly reports 4.6 ME/day 
Process   
% of patients given abdominal 
binders post-op 
Weekly audits of C/S patients in 
health connect 
90% 
% of patients given simethicone 
during admission 
Weekly audits of C/S patients in 
health connect  
80% 
% of patients given post-op pain 
management education upon arrival 
to M/B unit 
Weekly audits of C/S patients in 
health connect 
100% 
Balancing   
Average delta pain scores ERAS weekly reports < or = 0 
 
Team 
Project Lead J.W. 
RN Director  M.B 
RN Managers A.G, M.S. 
Project Champions M.Z., S.T., J.K. 
Project Physician Champions J.C 
QI/ERAS Champion R.P. 
OB CNS Educator H.C. 
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Measurement Strategy 
Background (Global Aim): To decrease the use of opioids and increase the utilization of non-
opioid options for pain management in women post-cesarean section delivery.  
 
Population Criteria: Postoperative cesarean section patients admitted to the M/B unit.  
 
Data Collection Method 
Data will be obtained through the weekly ERAS reports sent out by region and chart audits in the 
electronic medical record system Health Connect. Baseline data will be collected retrospectively 
using the data from previous ERAS weekly reports. Data will be evaluated weekly on all patients 
admitted to the M/B unit post-cesarean section after obtaining baseline data.  
Data Definitions 
Data Element Definition 
Rate of ME mg on M/B 
unit per 24 hours 
Rate per day of ME given from PACU discharge through POD3.  
Numerator: 24 x total ME mgs given from PACU discharge 
through POD3.  
Denominator: # hours starting at PACU discharge 
Delta pain score Delta pain = Pain score – Acceptable Level Pain 
Average Delta Pain Score 
Average delta pain score from 4 hours before OR entry through 
POD3 
Daily Abdominal binder 
Use 
Documentation in the EHR of the use of an abdominal per at 
minimum once per day.  
Postoperative Pain 
Management Education 
Documentation in the EHR of postoperative pain management 
education provided upon admission to the M/B unit.  
MMA administer per 
physicians’ orders 
Multimodal Analgesia (ibuprofen and Tylenol) given around the 
clock per physicians’ orders 
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Measure Description 





Rate per day of ME 
given from PACU 
discharge through 
POD3.  ERAS weekly reports 
To be within one 
standard deviation of 
the regional average 
ME/day 
% of patients given 
abdominal binders 
post-op 
Rate of cesarean 
section patients given 
abdominal binders 
Weekly audits of C/S 
patients in health 
connect 90% 









Weekly audits of C/S 
patients in health 
connect 80% 




arrival to M/B unit 
Rate of cesarean 
section patients given 
education on pain 
management upon 
admission to M/B 
unit 
Weekly audits of C/S 
patients in health 
connect 100% 
Average delta pain 
scores 
Average delta pain 
score from 4 hours 
before OR entry 
through POD3 ERAS weekly reports < 0 
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Appendix H. Driver Diagram 
 
  Aim Primary Drivers Secondary Drivers Change Ideas
Decrease floor ME/day for 
post cesarean section 
patients from 5.1 to 4.6 
ME/day by August 2021
C/S post-operative patients are 
given abdominal binders 
C/S post-operative patients are 
given MMA as prescribed 
through discharge
C/S patients are given post-
operative pain management 
education upon arrival to the 
MB unit
MB RNs to be educated on how to use 
abdominal binders
Patients educated on how to use 
abdominal binders
Correct sizing of abdominal binders
MB RNs are reeducated on 
importance of MMA and need to 
administer around the clock
Patients are educated on MMA and 
encourage to use around the clock
MB RNs trained on script on post-
operative pain management education 
for cesarean section patients
Patients are given visual 
representation of training to refer 
back to for pain management options 
post cesarean section. 
Inservice training provided to all MB 
RNs on how to size patients for 
abdominal binders, how to apply to 
patients, and where to chart use of 
abdominal binder
Provide MB RNs with script on 
educating patients on use of 
abdominal binders
Educate MB RNs on how to size a 
patient correctly for abdominal binders 
per manufactures instructions
MB RNs are provided with education on 
importance of MMA administered 
around the clock. 
Post C/S patients are educated on the 
importance of MMA administration 
around the clock
Creation of script for MB RNs to use in 
educating patients post cesarean 
section on pain management options 
Creation of a visual representation to 
give patients as a reminder of pain 
management options. 
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Appendix I. Gantt Chart-Project Timeline 
 
 
 Jan 2021 Feb 2021 Mar 2021 April 2021 May 2021 Ongoing 
Define the Project       
Develop the AIM       
Microsystem Assessment       
Literature Review       
Develop Charter       
Create Measurements, Outcomes, 
Processes, and Balances 
      
Identify Changes to test       
Driver Diagram       
Complete Charter       
Evaluation & Ongoing 
Performance Improvement 
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Appendix K. M/B versus Regional Average Floor  
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Appendix L. Average Delta Pain Score 
 
 
